CD4 + T follicular helper (T fH ) cells provide help to B cells and promote antibody-mediated immune responses. Increasing evidence supports the existence of T fH populations that secrete cytokines typically associated with the effector functions of other CD4 + T cell subsets. These include T helper 1 (T H 1)-biased T fH (T FH1 ) cells that have recognized roles in both immune responses to pathogens and also the pathogenesis of autoimmune disease. Given their apparent importance to human health, there is interest in understanding the mechanisms that regulate T FH1 cell formation and function. However, their origin and the molecular requirements for their differentiation are unclear. Here, we describe a population of murine T H 1-derived, T FH1 -like cells that express the chemokine receptor Cxcr3 and produce both the T H 1 cytokine interferon-γ and the T fH -associated cytokine interleukin-21 (IL-21). Furthermore, these T FH1 -like cells promote B cell activation and antibody production at levels indistinguishable from conventional IL-6-derived T fH -like cells. Regarding their regulatory requirements, we find that IL-12 signaling is necessary for the differentiation and function of this T FH1 -like cell population. Specifically, IL-12-dependent activation of STAT4, and unexpectedly STAT3, promotes increased expression of IL-21 and the T fH lineage-defining transcription factor Bcl-6 in T FH1 -like cells. Taken together, these findings provide insight into the potential origin and differentiation requirements of T FH1 cells.
of these cells, including the regulatory mechanisms that direct both their differentiation and function, remains enigmatic.
Here, we describe the step-by-step in vitro differentiation of a murine T H 1-derived, T FH1 -like cell population that exhibits phenotypic and functional characteristics similar to T FH1 cells observed in vivo, in both murine and human settings. Specifically, these cells express elevated levels of Cxcr3 and are capable of producing both IFN-γ and IL-21. Interestingly, we find that T FH1 -like cells provide B cell help similar to conventional T FH -like cells generated in the presence of IL-6. Mechanistically, we find that the differentiation and function of T FH1 -like cells requires IL-12-dependent activation of both STAT4 and STAT3, which cooperatively drive the expression of both Bcl-6 and IL-21. Finally, and somewhat surprisingly, we found that while STAT3 activation required signals from IL-12, it was independent of autocrine IL-21 signaling. Taken together, the findings presented here provide insight into the potential origin and differentiation requirements of recently described T FH1 cell populations that have increasingly recognized roles in host immune responses and autoimmune disease.
Results
t H 1-derived T FH1 -like cells express both T-bet and Bcl-6. Increasing evidence suggests that T FH cells exhibit considerable heterogeneity, and that phenotypically distinct T FH subsets arise in response to diverse immune challenges. These include T H 1-biased T FH1 cells, which secrete the cytokines IFN-γ and IL-21 and express the chemokine receptor Cxcr3 25, 29 . While T FH1 cells have been observed in a number of clinical and experimental settings in vivo, the regulatory mechanisms underlying their development remain unclear 20, 22, 27, 29 . A previous study from our laboratory demonstrated that T H 1 cells upregulate a T FH -like gene program in response to decreased signals from environmental IL-2 ( Supplementary Fig. 1A and 17 ). These findings were in agreement with several other studies demonstrating that IL-2 signaling is a potent repressor of T FH cell differentiation [30] [31] [32] . Given the T H 1 origin of this T FH -like population, we sought to determine whether these cells were phenotypically and functionally similar to T FH1 cells described in vivo.
A hallmark feature of T FH cell populations is their elevated expression of the transcriptional repressor Bcl-6 [33] [34] [35] . As such, we began by comparing Bcl-6 expression in in vitro-differentiated murine T H 1 cells, T H 1-derived T FH -like ('T FH1 -like') cells, previously described conventional T FH -like cells differentiated in the presence of IL-6 ('T FH0 -like'), and non-polarized T H 0 cells 36 (Fig. 1A ). Relative to T H 1 and T H 0 cells, both T FH1 -like and T FH0 -like populations displayed elevated expression of the T FH lineage-defining transcription factor Bcl-6 at both the transcript and protein level ( Fig. 1B,C) . In contrast, the Bcl-6 antagonist Blimp-1 was highly expressed only in the T H 1 cell population (Fig. 1B) . In addition to Bcl-6, T FH1 cells have also been shown to express the T H 1 lineage-defining transcription factor T-bet 18, 37 . As such, we next assessed T-bet expression levels across the above cell populations. Indeed, both transcript and protein analyses revealed that only the T FH1 -like population expressed both T-bet and Bcl-6 ( Fig. 1B,C) . Collectively, these data demonstrate that T H 1-derived T FH1 -like cells express both Bcl-6 and T-bet similar to findings from T FH1 cells observed in vivo 18,37 . t FH1 -like cells express elevated levels of Cxcr3, ICOS, and CD40 ligand. A second distinguishing feature of T FH1 cells found in vivo is elevated surface expression of the chemokine receptor Cxcr3 24, 25 . Indeed, gene expression analysis demonstrated that T FH1 -like cells had elevated levels of Cxcr3 expression compared to their T H 1 cell counterparts ( Supplementary Fig. 1B ). Therefore, we next used flow cytometric analysis to determine the relative expression of Cxcr3 on the surface of T FH1 -like and T FH0 -like populations. Indeed, T FH1 -like cells exhibited significantly more surface expression of Cxcr3 compared to the T FH0 population ( Fig. 2A) . Interestingly, two cell surface proteins that are critical for the B cell helper activity of T FH cells, ICOS and CD40 ligand, were also more highly expressed on T FH1 -like cells ( Fig. 2B ,C). To determine whether there were further differences in expression of the T FH gene program between the T FH1 -and T FH0 -like populations, we performed additional transcript analyses and found that, while there was no significant difference in the expression of Bcl6 or Btla, a number of other T FH -associated genes, including the chemokine receptor Cxcr5, were more highly expressed in the T FH0 -like population ( Fig. 1A and Supplementary Fig. 2A,B ). Conversely, as with ICOS and CD40 ligand, T FH1 -like cells expressed significantly higher levels of T FH genes known to be critical for effective B cell helper activity ( Supplementary Fig. 2C ). Taken together, these findings demonstrate that T FH1 -like cells preferentially express Cxcr3 alongside a number of proteins required to provide T cell help to B cells.
t FH1 -like cells produce both IFN-γ and IL-21. A functional characteristic of T FH1 cell populations is their
expression of both IL-21 and IFN-γ 29, 38 . To determine whether T FH1 -like cells similarly exhibit this function, we evaluated their ability to simultaneously produce IL-21 and IFN-γ via flow cytometry. While both T FH1 -like and T FH0 -like populations expressed IL-21, T FH1 -like cells were superior producers of IFN-γ ( Fig. 3A,B ). Importantly, a significantly higher percentage of T FH1 -like cells were IFN-γ + IL-21 + , as compared to the T FH0 -like population ( Fig. 3C ). Interestingly, we did not observe significant differences in the expression of either IFN-γ or IL-21 between T H 1 and T FH1 -like cells ( Supplementary Fig. 1C ). This was interesting, as it has been reported that IFN-γ expression is subject to Bcl-6-dependent repression during the differentiation of conventional T FH cell populations 35 . Collectively, these data demonstrate that in addition to exhibiting a T FH1 phenotype, T H 1-derived T FH1 -like cells also exhibit functional characteristics associated with T FH1 cells in the form of dual production of IFN-γ and IL-21 18,25 . t FH1 -like cells are capable of activating B cells and inducing antibody production. To extend our functional analyses, we next compared B cell helper activity between the two T FH -like populations. Consistent with their increased IL-21 production and expression of T FH cell markers, both T FH -like cell populations were more effective at promoting B cell activation than non-polarized T H 0 cells ( Fig. 4A,B ). Furthermore, co-culture experiments demonstrated that both T FH -like populations were capable of inducing antibody production by B cells, while T H 0 cells were poor providers of B cell help ( Fig. 4C ). Interestingly, we did not observe differences in the ability of T FH0 -like and T FH1 -like cells to preferentially induce isotype switching. This may be due to the presence of multiple cytokines in the culture media, including both IL-21 and IFN-γ, as well as others that were not analyzed (e.g. IL-10). Regardless, our data support a functional role for T FH1 -like cells, similar to that of T FH0 -like cells, in supporting B cell antibody production ( Fig. 4C ). Together, these data demonstrate that T H 1-derived T FH1 -like cells are capable of performing functions attributed to bona fide T FH cells and, interestingly, are functionally similar to more conventional IL-6-derived T FH cells 19,25,27 . t fH gene expression patterns and B cell helper activity are dependent upon IL-12. We next sought to determine specific cytokine signals and transcription factors responsible for driving the T FH1 -like phenotype. A notable difference between the T FH1 -like and T FH0 -like cell populations is that the T H 1-derived T FH1 -like cells are cultured in the presence of IL-12, rather than IL-6. While IL-12 has been reported to be an important factor in the in vitro and in vivo differentiation of human T FH cell populations, the role of IL-12 in promoting murine T FH cell differentiation is less clear [39] [40] [41] [42] . In order to assess the role of IL-12 in T FH1 -like cell differentiation, we cultured T FH1 -like cells with and without IL-12 and assessed their expression of notable T FH1 cell transcription factors and cell surface receptors. Strikingly, expression of both T-bet and Bcl-6 was significantly reduced in the Briefly, naïve CD4 + T cells were cultured on plate-bound anti-CD3 and anti-CD28 as follows: T H 1 (5 ng/mL IL-12, 5 μg/mL anti-IL-4), T FH0 -like (50 ng/mL IL-6, 10 μg/mL anti-IL-4, 10 μg/mL anti-IFN-γ), or T H 0 (10 μg/mL anti-IL-4, 10 μg/mL anti-IFN-γ). After 3 days, cells were removed from stimulation and plated under the following conditions: T H 1 (5 ng/mL rmIL-12, 2.5 μg/mL anti-IL-4, 500 U/mL rhIL-2), T FH1 -like (expanded from T H 1 population; 5 ng/mL rmIL-12, 2.5 μg/mL anti-IL-4, 10 U/mL rhIL-2), T FH0 -like (10 μg/mL anti-IL-4, 10 μg/mL anti-IFN-γ, 50 ng/mL rmIL-6, 10 U/mL rhIL-2), or T H 0 (10 μg/mL anti-IL-4, 10 μg/mL anti-IFN-γ, 10 U/mL IL-2) for an additional 2 days. (B) qRT-PCR was used to assess expression of the indicated genes. The data were normalized to Rps18 and presented as fold change relative to the T FH1 -like sample (mean of n = 4-7 ± s.e.m.). **P < 0.01, ***P < 0.001; one-way ANOVA with Tukey multiple-comparison test. (C) Immunoblot analysis of Bcl-6 and T-bet protein expression in the indicated T helper cell populations. β-actin serves as a loading control. Shown is a representative blot of four independent experiments. absence of IL-12 ( Fig. 5A,B ). Additional analyses revealed that while many T FH genes were unaffected by the loss of IL-12, the expression of the key T FH -associated gene Icos was significantly reduced at both the transcript and protein level ( Supplementary Fig. 3 ).
We next wanted to assess the importance of IL-12 signaling to T FH1 -like cell function. As such, we assessed the ability of T FH1 -like cells cultured in the presence and absence of IL-12 to produce cytokines and induce B cell-mediated antibody production. Importantly, production of IL-21 and IFN-γ, as well as the percentage of IFN-γ + IL-21 + cells, was reduced in the absence of signals from IL-12 ( Fig. 5C-E ). Furthermore, T FH1 -like cells cultured without IL-12 were poor inducers of B cell antibody production as compared to IL-12-cultured controls (Fig. 5F ). Taken together, these data demonstrate that IL-12 signaling is a potent inducer of the phenotypic and functional properties of T FH1 -like cells. STAT4 and STAT3 associate with the Bcl6 and Il21 loci downstream of IL-12 signaling. We next sought to identify transcription factors downstream of IL-12 signaling that may regulate expression of key T FH genes in T FH1 -like cells. We began by focusing on STAT4, which is activated (phosphorylated) downstream of signals from IL-12 ( Fig. 6A ). A previous study described STAT4 association with the Bcl6 and Il21 loci 42 . Indeed, we observed increased STAT4 enrichment at both the Bcl6 and Il21 promoters in T FH1 -like cells cultured in the presence of IL-12, as compared to cells cultured without IL-12 ( Fig. 6B-D) . These findings suggest that STAT4 is a positive regulator of both Bcl-6 and IL-21 expression in T FH1 -like cells.
In addition to STAT4, STAT3 has also been identified as an important positive regulator of T FH gene expression 5, 17, 43, 44 . STAT3 is activated in response to signaling from a number of cytokines including IL-21. Our previous findings demonstrated that IL-12 signaling was a potent driver of IL-21 expression by the T FH1 -like population. As such, we considered the possibility that STAT3 activation may also require upstream signals from IL-12 in T FH1 -like cells. Indeed, we found that STAT3 activation was reduced in the absence of IL-12 (Fig. 6E ). Consistent with these data, we observed decreased STAT3 enrichment at the Bcl6 and Il21 promoters in T FH1 -like cells cultured without IL-12 (Fig. 6F,G) . We next sought to determine whether the observed STAT3 activation was due to IL-12-dependent, autocrine IL-21 signaling. However, we observed no difference in STAT3 activation or in the expression of Bcl-6 when IL-21R-deficient cells were differentiated under T FH1 -like polarizing conditions, suggesting that STAT3 activation downstream of IL-12 signals was independent of IL-21 (Supplementary Figs. 4A-C). Collectively, these data implicate cooperative, IL-12-dependent activities of both STAT4 and STAT3 in the differentiation and functional regulation of T FH1 -like cells.
Discussion
Recent work has established that T H 1-biased T FH cell populations exist in vivo and that these cells play roles in both healthy immune responses and autoimmune disease 20, 24, 25, 28, 29 . To date, the cytokine signals and transcriptional mechanisms underlying their formation and function are unclear. Here, we demonstrate that in vitro-generated T H 1 cells are capable of differentiating into a T FH1 -like cell population that exhibits phenotypic and functional characteristics associated with T FH1 cells. Similar to T FH1 cells described in vivo, T FH1 -like cells express both the T FH lineage-defining factor Bcl-6 and the T H 1 lineage-defining factor T-bet, in addition to the chemokine receptor Cxcr3. Functionally, our findings demonstrate that the T FH1 -like cell population is capable of producing both IFN-γ and IL-21 and providing help to B cells that results in B cell activation and antibody production. While there is a general consensus on the phenotypic and functional properties of T FH1 cells, there is still a debate as to their cellular origin. The findings presented here support a developmental pathway wherein T H 1 cells give rise to a hybrid T FH1 -like cell state by inducing the expression of Bcl-6 and other aspects of the T FH gene program. In agreement with our findings, a recent report demonstrated that IFN-γ-producing T FH cells generated in vivo require prior expression of T-bet 37 . Alternatively, it has been suggested that T FH1 cells are conventional T FH cells that gain T-bet expression and the ability to produce IFN-γ 29 . While our work does not necessarily support this model, it is important to note that our findings also do not exclude this as a potential mechanism. Future studies will be necessary to determine whether a dominant differentiation pathway for T FH1 cells exists or whether there may be multiple origins from which these specialized T FH cell populations arise.
Our current findings also provide mechanistic insight into the potential cytokine signals and downstream transcriptional mechanisms required for the differentiation of T FH1 cells. In this regard, we find that the expression of a number of genes that promote induction of the T FH1 -like cell state is dependent upon signals from the cytokine IL-12. Specifically, we find that IL-12 is required for the elevated expression of Bcl-6 and ICOS that is observed in the T FH1 -like population, as well as the production of IFN-γ and IL-21. These data are in agreement with previous work in human cells demonstrating that IL-12 is required for the development of a CD4 + T cell population that co-expresses IFN-γ and IL-21 26 . Furthermore, our findings are also in agreement with work identifying a role for IL-12 in positively regulating the development and function of human T FH cells in both in vitro and in vivo settings 40, 41, 43, 45 . www.nature.com/scientificreports www.nature.com/scientificreports/ Interestingly, while the role of IL-12 in human T FH cell development is relatively well defined, the requirement for IL-12 signals in murine T FH differentiation is less clear 16, 18, 42 . As a potential explanation for this discrepancy, we find that while IL-12 signaling in the form of STAT4 and STAT3 activation is required to drive the expression www.nature.com/scientificreports www.nature.com/scientificreports/ of a subset of T FH genes, including Bcl6, Icos, and Il21, signals from IL-12 appear to play a complementary but secondary role to those derived from IL-2 17 . Thus, our findings support a model wherein combined IL-12 and IL-2 signals drive T H 1 cell differentiation, while IL-12 signals in the absence of strong IL-2 signaling promote the alternative T FH1 -like phenotype. Indeed, our previous work, and that of others, has demonstrated that the IL-2/ STAT5 signaling axis functions as a potent negative regulator of T FH cell development 17, [30] [31] [32] .
Intriguingly, our work implicates an IL-12/STAT4/STAT3 signaling axis in the positive regulation of T FH1 cell development, as IL-12 signaling is required for both STAT4 and STAT3 activation in the T FH1 -like population. In agreement with these findings, STAT4 activation has been previously implicated in the generation of IFNγ-producing T-bet + Bcl-6 + T FH cells generated in response to viral infection 18 . Though our findings suggest that IL-12-dependent activation of STAT3 promotes the expression of the T FH1 phenotype, the identity of the signals that drive the phosphorylation of STAT3 remain unclear. Classically, IL-12 signaling has been associated with STAT4 activation. However, previous work has indicated that IL-12 signals are also capable of inducing STAT3 activation 46 . We also considered the possibility that STAT3 activation may arise from autocrine IL-21 signaling. However, experiments with IL-21R −/− T cells demonstrated that STAT3 activation is independent of IL-21. Thus, whether STAT3 activation is occurring directly downstream of IL-12 signaling, or downstream of signals from an IL-12-dependent cytokine, is as yet unclear.
Collectively, the work presented here supports a possible T H 1 origin for the T FH1 cells observed in vivo, and also provides insights into the regulatory requirements that govern their development. Given their role in infection and autoimmune disease, a better understanding of such regulatory requirements may identify potential therapeutic targets, which will allow for more selective manipulation of T FH1 cell populations in efforts to treat human disease.
Methods
Primary cells and cell culture. All mouse strains [C57BL/6J, C57BL/6NJ, IL-21R −/− (C57BL/6NJ background)] were obtained from the Jackson Laboratory. Naïve CD4 + T cells were purified from the spleens and lymph nodes of 5-8 week old mice via negative selection using the BioLegend Mojosort kit according to the manufacturer's instructions. For all experiments, cells were cultured in complete IMDM ("cIMDM": IMDM [Life Technologies], 10% FBS [Life Technologies], 1% Penicillin-Streptomycin [Life Technologies], and 50 μM β-mercaptoethanol [Sigma-Aldrich]). Following isolation, cells were plated at a density of 3-5 × 10 5 cells per well and stimulated using plate-bound anti-CD3ε (5 µg/ml; BD Biosciences) and anti-CD28 (10 μg/ml; BD Biosciences) under the following polarizing conditions: T H 1 (5 ng/mL rmIL-12 [R&D Systems], 5 μg/mL anti-IL-4), T FH0like (10 μg/mL anti-IFN-γ, 10 μg/mL anti-IL-4, 50 ng/mL rmIL-6 [R&D Systems]), T H 0 (10 μg/mL anti-IFN-γ [XMG1.2; BioLegend], 10 μg/mL anti-IL-4 [11B11; BioLegend]). After 3 days, cells were removed from stimulation and expanded to plate at 5-7 × 10 5 cells/well in fresh media under the following conditions: T H 1 (5 ng/ mL rmIL-12, 2.5 μg/mL anti-IL-4, 500 U/mL rhIL-2 [NIH]), T FH1 -like (expanded from T H 1 population; 5 ng/mL rmIL-12, 2.5 μg/mL anti-IL-4, 10 U/mL rhIL-2), T FH0 -like (10 μg/mL anti-IFN-γ, 10 μg/mL anti-IL-4, 50 ng/mL rmIL-6, 10 U/mL rhIL-2), T H 0 (10 μg/mL anti-IFN-γ, 10 μg/mL anti-IL-4, 10 U/mL IL-2) for an additional 48 h. Where indicated, IL-12 was omitted from the T FH1 -like culturing conditions. The Institutional Animal Care and Use Committee of Virginia Tech approved all experiments involving the use of mice. All methods were performed in accordance with the approved guidelines.
T and B cell co-culture and analysis of helper activity. B cells were purified from the spleens and lymph nodes of age-and sex-matched 5-8 week old C57BL/6J mice using the MojoSort Mouse Pan B cell isolation kit (BioLegend), according to the manufacturer's instructions. For each indicated population, 1 × 10 5 T cells were mixed with B cells at a 1:3 T cell:B cell ratio and stimulated using plate-bound anti-CD3ε (5 μg/mL) under T FH1 -like or T FH0 -like conditions. Where indicated, IL-12 was omitted from the T FH1 -like conditions. T and B cells were co-cultured for either 2 days, at which point B cell activation was analyzed by flow cytometry, or 4 days, where supernatant was collected for ELISA analysis of antibody production.
Antibody production was measured using the BD Pharmingen Mouse Immunoglobulin Isotyping ELISA kit according to the manufacturer's instructions. OD450 values were calculated by subtracting OD450 readings taken from supernatants from B cells cultured alone in the indicated polarizing conditions from the OD450 values of co-cultured samples.
